Resmed (RMD) Capital Expenditures (2009 - 2026)

Resmed has reported Capital Expenditures for 18 years, with the latest figure at $33.7 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures rose 61.83% year-over-year to $33.7 million; the trailing twelve-month figure through Mar 2026 stood at $135.7 million (up 61.29% YoY), and the FY2025 full-year result was $89.9 million, down 9.65% from the prior year.
• Capital Expenditures for Q1 2026 stood at $33.7 million, up from $28.5 million in the prior quarter.
• The five-year high for Capital Expenditures was $48.4 million in Q1 2022, with the low at $17.8 million in Q3 2024.
• Historically, Capital Expenditures has averaged $28.9 million across 5 years, with a median of $28.6 million in 2022.
• Annual changes were most pronounced in 2024 — Capital Expenditures sank 40.6% — and 2025, when it jumped 140.84%.
• Resmed's Capital Expenditures stood at $27.4 million in 2022, then dropped by 14.61% to $23.4 million in 2023, then dropped by 11.6% to $20.6 million in 2024, then surged by 38.24% to $28.5 million in 2025, then rose by 17.92% to $33.7 million in 2026.
• The last three Capital Expenditures figures came in at $33.7 million (Q1 2026), $28.5 million (Q4 2025), and $43.0 million (Q3 2025), per Business Quant data.